000 02289nam a2200289 4500
001 11003
010 _a9789291685615
090 _a11003
100 _a20180830d2012 y0pory50 ba
101 _aeng
200 _aPrisons and drugs in Europe
_ethe problem and responses EMCDDA Selected issues
_fEuropean Monitoring Centre for Drugs and Drug Addiction
210 _aLuxembourg
_cPubications Office of the European Union
_d2012
215 _a31 p.
_cil.
_d30 cm
330 _aThis Selected issue starts off by reviewing the available data on drug use among prison populations in Europe, focusing on injecting drug use and other health risk behaviours. Major health risks for drug-using prisoners, including blood-borne infections and infections that can affect all prisoners equally, such as tuberculosis, are discussed. Also mentioned is the role of prison environments, where overcrowding and unsanitary conditions are not uncommon, and the higher-than-average occurrence of psychiatric problems among prisoners. The first section concludes by describing the increased risk of death among prisoners, both in custody and after release. The second part of the report focuses on responses to the health needs of drug-using prisoners in European countries. The study looks at how the internationally recognised rights of prisoners and the European and international rules that set standards for the care of prisoners apply to those with drug problems. The administration of prison healthcare in European countries is examined, and national policies are reviewed. This is followed by an overview of the available information on drug-related service provision in Europe, from prison entry to prison release, addressing counselling, treatment of drug dependence and the prevention of infectious diseases and drug overdose
606 _aMEDICINA
_91408
606 _aMEDICINA NA PRISÃO
_9104985
606 _aADMINISTRAÇÃO PENITENCIÁRIA
_9560
606 _aPRESO
_9942
606 _aPREVENÇÃO
_91401
606 _aDOENÇAS TRANSMISSÍVEIS
_94927
606 _aHEPATITE
_9104361
606 _aSIDA
_94926
606 _aUNIÃO EUROPEIA
_9100
710 _aEuropean Monitoring Centre for Drugs and Drug Addiction
_911925
852 _j61EUR